Form 4: Teladoc Executive Sells Shares for Tax Obligations

Teladoc Health's President, International, Carlos Nueno, sold shares to cover tax obligations following the vesting of performance and restricted stock units.

Summary

• Carlos Nueno, President, International of Teladoc Health, Inc. (TDOC), reported transactions involving the acquisition and disposal of common stock.
• On August 29, 2025, Nueno acquired 1,056 shares of common stock from the conversion of Performance Stock Units (PSUs) and an additional 7,656 shares from the conversion of Restricted Stock Units (RSUs).
• These conversions increased his direct beneficial ownership of Teladoc Health common stock.
• On September 2, 2025, Nueno sold 3,998 shares of Teladoc Health common stock at a price of $7.585 per share.
• The sale was specifically conducted to cover tax withholding obligations associated with the vesting of his PSU and RSU awards.
• Following these reported transactions, Carlos Nueno directly beneficially owns 22,359 shares of Teladoc Health common stock.
• He also continues to hold 2,117 Performance Stock Units and 33,540 Restricted Stock Units (comprising 6,202 and 27,338 units respectively) that are subject to future vesting.

Sentiment

Score: 6

Explanation: The transactions primarily reflect the routine vesting of equity awards and subsequent sale of shares to cover tax obligations, which is a common practice for executives. It does not indicate a discretionary sale based on a change in outlook, thus maintaining a neutral to slightly positive sentiment due to continued executive alignment.

Positives

• The vesting of performance and restricted stock units indicates the achievement of performance metrics or continued service, aligning executive interests with shareholder value.
• The conversion of PSUs and RSUs into common stock increases the executive's direct equity stake in the company (prior to the tax-related sale).

Negatives

• The sale of 3,998 shares by an insider, even for tax purposes, can sometimes be perceived negatively by the market, potentially signaling a lack of confidence, although in this context, it is a routine event.

Risks

• Market perception risk: While a routine tax-related sale, any insider selling can be misconstrued by the market as a lack of confidence, potentially leading to short-term negative sentiment.

Future Outlook

The remaining Performance Stock Units (2,117) and Restricted Stock Units (33,540) held by Carlos Nueno are subject to future vesting schedules, indicating continued equity incentives and alignment with the company's long-term performance.

Management Comments

• Shares were sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Industry Context

NA

Stakeholder Impact

• Shareholders: May observe a slight increase in shares available on the market due to the sale, but the overall impact is minimal given the routine nature of the transaction. The vesting of awards aligns executive incentives with long-term shareholder value.

Next Steps

• Continued vesting of the remaining 2,117 Performance Stock Units and 33,540 Restricted Stock Units held by Carlos Nueno according to their respective schedules.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of equity awards and a subsequent sale of shares to cover tax obligations. Such transactions are common and typically pre-planned, not indicative of a change in the company's fundamental outlook or the insider's confidence. Therefore, it does not provide new information that would warrant a change in investment recommendation.

Keywords

Teladoc Health, TDOC, Insider Transaction, Form 4, Executive Compensation, Stock Units, Restricted Stock Units, Performance Stock Units, Carlos Nueno